{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:44:37Z","timestamp":1791265477027,"version":"4.1.0"},"reference-count":43,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:p>OBJECTIVES. The objectives of this study were to determine the prevalence of hyperglycemia in extremely low birth-weight infants and to determine whether hyperglycemia increases the risk of early adverse outcomes (death or intraventricular hemorrhage of grade 3 or 4) and\/or affects the length of hospital stay among survivors without intraventricular hemorrhage.<\/jats:p><jats:p>METHODS. The charts of all extremely low birth-weight infants (n = 93) admitted to Texas Children's Hospital (Houston, TX) during 2001 were reviewed. The highest daily blood glucose concentrations, highest dopamine infusion rates, highest daily percentage of inspired oxygen, and mean blood sodium concentrations were averaged over the first week of life or before death or occurrence of grade 3 or 4 intraventricular hemorrhage. Among survivors without severe intraventricular hemorrhage, the time ratio for blood glucose concentrations of &amp;gt;150 mg\/dL was calculated.<\/jats:p><jats:p>RESULTS. More than 50% of the infants had persistent blood glucose concentrations of &amp;gt;150 mg\/dL during their first week of life. Early adverse outcomes were associated with the average highest daily blood glucose concentration through interaction with the Clinical Risk Index for Babies score and with the average highest daily percentage of inspired oxygen. The length of hospital stay was associated with the time ratio for blood glucose concentrations of &amp;gt;150 mg\/dL through interaction with birth weight and the average highest daily percentage of inspired oxygen.<\/jats:p><jats:p>CONCLUSION. These data confirm the high prevalence of hyperglycemia among parenterally fed, extremely low birth-weight infants and show that high blood glucose concentrations increase the risk of early death and grade 3 or 4 intraventricular hemorrhage and the length of hospital stay among survivors without intraventricular hemorrhage, which suggests that prevention and treatment of hyperglycemia may improve the outcomes of extremely low birth-weight infants.<\/jats:p>","DOI":"10.1542\/peds.2006-0628","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T18:04:44Z","timestamp":1162490684000},"page":"1811-1818","source":"Crossref","is-referenced-by-count":250,"title":["Hyperglycemia Is a Risk Factor for Early Death and Morbidity in Extremely Low Birth-Weight Infants"],"prefix":"10.1542","volume":"118","author":[{"given":"Stephane P.","family":"Hays","sequence":"first","affiliation":[{"name":"US Department of Agriculture\/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. O'Brian","family":"Smith","sequence":"additional","affiliation":[{"name":"US Department of Agriculture\/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta L.","family":"Sunehag","sequence":"additional","affiliation":[{"name":"US Department of Agriculture\/Agricultural Research Service Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2021120823214026500_R1","doi-asserted-by":"crossref","unstructured":"Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet.\u20082000;355:773\u2013778","DOI":"10.1016\/S0140-6736(99)08415-9"},{"key":"2021120823214026500_R2","doi-asserted-by":"crossref","unstructured":"Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke.\u20082001;32:2426\u20132432","DOI":"10.1161\/hs1001.096194"},{"key":"2021120823214026500_R3","doi-asserted-by":"crossref","unstructured":"Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma.\u20082004;56:1058\u20131062","DOI":"10.1097\/01.TA.0000123267.39011.9F"},{"key":"2021120823214026500_R4","doi-asserted-by":"crossref","unstructured":"Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma.\u20082005;58:921\u2013924","DOI":"10.1097\/01.TA.0000162141.26392.07"},{"key":"2021120823214026500_R5","doi-asserted-by":"crossref","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab.\u20082002;87:978\u2013982","DOI":"10.1210\/jcem.87.3.8341"},{"key":"2021120823214026500_R6","doi-asserted-by":"crossref","unstructured":"Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med.\u20082004;5:329\u2013336","DOI":"10.1097\/01.PCC.0000128607.68261.7C"},{"key":"2021120823214026500_R7","doi-asserted-by":"crossref","unstructured":"Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr.\u20082005;14:30\u201334","DOI":"10.1016\/j.jpeds.2004.08.076"},{"key":"2021120823214026500_R8","doi-asserted-by":"crossref","unstructured":"Branco RG, Garcia PCR, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med.\u20082005;6:470\u2013472","DOI":"10.1097\/01.PCC.0000161284.96739.3A"},{"key":"2021120823214026500_R9","doi-asserted-by":"crossref","unstructured":"Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc.\u20082004;79:992\u20131000","DOI":"10.4065\/79.8.992"},{"key":"2021120823214026500_R10","doi-asserted-by":"crossref","unstructured":"van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med.\u20082001;345:1359\u20131367","DOI":"10.1056\/NEJMoa011300"},{"key":"2021120823214026500_R11","doi-asserted-by":"crossref","unstructured":"Ertl T, Gyarmati J, Gaal V, Szabo I. Relationship between hyperglycemia and retinopathy of prematurity in very low birth weight infants. Biol Neonate.\u20082006;89:56\u201359","DOI":"10.1159\/000088199"},{"key":"2021120823214026500_R12","doi-asserted-by":"crossref","unstructured":"Lilien LD, Rosenfield RL, Baccaro MM, Pildes RS. Hyperglycemia in stressed small premature neonates. J Pediatr.\u20081979;94:454\u2013459","DOI":"10.1016\/S0022-3476(79)80601-0"},{"key":"2021120823214026500_R13","doi-asserted-by":"crossref","unstructured":"Louik C, Mitchell AA, Epstein MF, Shapiro S. Risk factors for neonatal hyperglycemia associated with 10% dextrose infusion. Am J Dis Child.\u20081985;193:783\u2013786","DOI":"10.1001\/archpedi.1985.02140100045025"},{"key":"2021120823214026500_R14","unstructured":"Cowett AA, Farrag HM, Gelardi NL, Cowett RM. Hyperglycemia in the micropremie: evaluation of the metabolic disequilibrium during the neonatal period. Prenat Nenonatal Med.\u20081997;2:360\u2013365"},{"key":"2021120823214026500_R15","unstructured":"Wu S, Srinivasan G, Pildes RS, Patel MK. Plasma glucose values during first month of life in infants &lt;1000 gm. Pediatr Res.\u20081990;27:231A"},{"key":"2021120823214026500_R16","doi-asserted-by":"crossref","unstructured":"Dweck HS, Cassady G. Glucose intolerance in infants of very low birth weight, part I: incidence of hyperglycaemia in infants of birth weights 1,100 grams and less. Pediatrics.\u20081974;53:189\u2013195","DOI":"10.1542\/peds.53.2.189"},{"key":"2021120823214026500_R17","doi-asserted-by":"crossref","unstructured":"Miranda LE, Dweck HS. Perinatal glucose homeostasis: the unique character of hyperglycemia and hypoglycemia in infants of very low birth weight. Clin Perinatol.\u20081977;4:351\u2013365","DOI":"10.1016\/S0095-5108(18)31211-9"},{"key":"2021120823214026500_R18","doi-asserted-by":"crossref","unstructured":"Pildes RS. Neonatal hyperglycemia. J Pediatr.\u20081986;109:905\u2013907","DOI":"10.1016\/S0022-3476(86)80725-9"},{"key":"2021120823214026500_R19","doi-asserted-by":"crossref","unstructured":"Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants: National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med.\u20082001;344:95\u2013101","DOI":"10.1056\/NEJM200101113440203"},{"key":"2021120823214026500_R20","doi-asserted-by":"crossref","unstructured":"Meetze W, Bowsher R, Compton J, Moorehead H. Hyperglycemia in extremely-low-birth-weight infants. Biol Neonate.\u20081998;74:214\u2013221","DOI":"10.1159\/000014027"},{"key":"2021120823214026500_R21","doi-asserted-by":"crossref","unstructured":"Grasso S, Distefano G, Messina A, Vigo R, Reitano G. Effect of glucose priming on insulin response in the premature infant. Diabetes.\u20081975;24:291\u2013294","DOI":"10.2337\/diabetes.24.3.291"},{"key":"2021120823214026500_R22","doi-asserted-by":"crossref","unstructured":"Ktorza A, Bihoreau MT, Nurjhan N, Picon L, Girard J. Insulin and glucagon during the perinatal period: secretion and metabolic effects on the liver. Biol Neonate.\u20081985;48:204\u2013220","DOI":"10.1159\/000242173"},{"key":"2021120823214026500_R23","doi-asserted-by":"crossref","unstructured":"Reitano G, Grasso S, Distefano G. The serum insulin and growth hormone response to arginine and arginine with glucose in the premature infant. J Clin Endocrinol Metab.\u20081971;33:924\u2013928","DOI":"10.1210\/jcem-33-6-924"},{"key":"2021120823214026500_R24","doi-asserted-by":"crossref","unstructured":"Kalhan SC, Oliven A, King KC, Lucero C. Role of glucose in the regulation of endogenous glucose production in the human newborn. Pediatr Res.\u20081986;10:49\u201352","DOI":"10.1203\/00006450-198601000-00013"},{"key":"2021120823214026500_R25","doi-asserted-by":"crossref","unstructured":"Gruenwald P, Minh HN. Evaluation of body and organ weights in perinatal pathology, part I: normal standards derived from autopsies. Am J Clin Pathol.\u20081960;34:247\u2013253","DOI":"10.1093\/ajcp\/34.3.247"},{"key":"2021120823214026500_R26","doi-asserted-by":"crossref","unstructured":"Widdowson EM, Spray CM. Chemical development in utero. Arch Dis Child.\u20081951;26:205\u2013214","DOI":"10.1136\/adc.26.127.205"},{"key":"2021120823214026500_R27","unstructured":"Ziegler EE, O'Donnell AM, Nelson SE, Fomon SJ. Body composition of the reference fetus. Growth.\u20081976;40:329\u2013341"},{"key":"2021120823214026500_R28","doi-asserted-by":"crossref","unstructured":"Stonestreet BS, Rubin L, Pollak A, Cowett RM, Oh W. Renal functions of low birth weight infants with hyperglycemia and glucose produced by glucose infusion. Pediatrics.\u20081980;66:561\u2013567","DOI":"10.1542\/peds.66.4.561"},{"key":"2021120823214026500_R29","doi-asserted-by":"crossref","unstructured":"Finberg L. Dangers to infants caused by changes in osmolal concentration. J Pediatr.\u20081967;40:1031\u20131034","DOI":"10.1542\/peds.40.6.1031"},{"key":"2021120823214026500_R30","doi-asserted-by":"crossref","unstructured":"Vohr B, Ment LR. Intraventricular hemorrhages in the preterm infant [published correction appears in Early Hum Dev. 1996;45:169]. Early Hum Dev\u20081996;44:1\u201316","DOI":"10.1016\/0378-3782(95)01692-9"},{"key":"2021120823214026500_R31","doi-asserted-by":"crossref","unstructured":"Volpe JJ. Brain injury in the premature infant: neuropathology, clinical aspects, pathogenesis, and prevention. Clin Perinatol.\u20081997;24:567\u2013587","DOI":"10.1016\/S0095-5108(18)30159-3"},{"key":"2021120823214026500_R32","doi-asserted-by":"crossref","unstructured":"Bier DM, Leake RD, Haymond MW, et al. Measurement of \u201ctrue\u201d glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes.\u20081977;26:1016\u20131023","DOI":"10.2337\/diab.26.11.1016"},{"key":"2021120823214026500_R33","doi-asserted-by":"crossref","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H, Koops B. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr.\u20081978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120823214026500_R34","doi-asserted-by":"crossref","unstructured":"Fenton RF. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr.\u20082003;3:13","DOI":"10.1186\/1471-2431-3-13"},{"key":"2021120823214026500_R35","doi-asserted-by":"crossref","unstructured":"International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet.\u20081993;342:193\u2013198","DOI":"10.1016\/0140-6736(93)92296-6"},{"key":"2021120823214026500_R36","doi-asserted-by":"crossref","unstructured":"Sunehag A, Ewald U, Larsson A, Gustafsson J. Glucose production rate in extremely immature neonates (&lt;28 w) studied by use of deuterated glucose. Pediatr Res.\u20081993;33:97\u2013100","DOI":"10.1203\/00006450-199302000-00001"},{"key":"2021120823214026500_R37","doi-asserted-by":"crossref","unstructured":"Tyrala EE, Chen X, Boden G. Glucose metabolism in the infant weighing less than 1100 grams. J Pediatr.\u20081994;125:283\u2013287","DOI":"10.1016\/S0022-3476(94)70212-8"},{"key":"2021120823214026500_R38","doi-asserted-by":"crossref","unstructured":"Sunehag A, Ewald U, Gustafsson J. Extremely preterm infants (&lt;28 weeks) are capable of gluconeogenesis from glycerol on their first day of life. Pediatr Res.\u20081996;40:553\u2013557","DOI":"10.1203\/00006450-199610000-00007"},{"key":"2021120823214026500_R39","doi-asserted-by":"crossref","unstructured":"Cowett RM, Oh W, Schwartz R. Persistent glucose production during glucose infusion in the neonate. J Clin Invest.\u20081983;71:467\u2013475","DOI":"10.1172\/JCI110791"},{"key":"2021120823214026500_R40","doi-asserted-by":"crossref","unstructured":"Sunehag A, Gustafsson J, Ewald U. Very immature infants (\u226430 weeks) respond to glucose infusion with incomplete suppression of glucose production. Pediatr Res.\u20081994;36:550\u2013557","DOI":"10.1203\/00006450-199410000-00024"},{"key":"2021120823214026500_R41","doi-asserted-by":"crossref","unstructured":"Farrag HM, Nawrath LM, Healey JE, et al. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. Am J Physiol.\u20081997;272:E86\u2013E93","DOI":"10.1152\/ajpendo.1997.272.1.E86"},{"key":"2021120823214026500_R42","doi-asserted-by":"crossref","unstructured":"Cowett RM, Oh W, Pollak A, Schwartz R, Stonestreet BS. Glucose disposal of low birth weight infants: steady state hyperglycemia produced by constant intravenous glucose infusion. Pediatrics.\u20081979;63:389\u2013396","DOI":"10.1542\/peds.63.3.389"},{"key":"2021120823214026500_R43","doi-asserted-by":"crossref","unstructured":"Hey E. Hyperglycaemia and the very preterm baby. Semin Fetal Neonatal Med.\u20082005;10:377\u2013378","DOI":"10.1016\/j.siny.2005.04.008"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/1811\/1117714\/zpe01106001811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/1811\/1117714\/zpe01106001811.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T16:32:55Z","timestamp":1683649975000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/5\/1811\/69943\/Hyperglycemia-Is-a-Risk-Factor-for-Early-Death-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":43,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-0628","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}